In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ViiV Healthcare

Division of GlaxoSmithKline PLC
www.viivhealthcare.com

Latest From ViiV Healthcare

US Approval For ViiV’s ‘Last Resort’ HIV Drug Rukobia

The US FDA has given the go-ahead for marketing of ViiV healthcare’s novel HIV drug just as the EMA removes the accelerated assessment status from its application there.

Approvals Infectious Diseases

ViiV’s Fostemsavir Loses EU Fast-Track Status

Viiv Healthcare's marketing application for fostemsavir started off being fast-tracked through the review process at the European Medicines Agency in January but is now being reviewed under standard timelines. The product is being developed for the treatment of adults with multidrug resistant HIV-1 infection.

Europe Drug Review

High Efficacy Halts ViiV HIV Prevention Study Early

Prospects have improved for ViiV’s long-acting, injectable cabotegravir to be approved early for HIV prevention after a Phase III trial was stopped early due to efficacy.

Clinical Trials Companies

EU Accelerated Assessment Tracker

Alnylam and Eiger join the select group of companies whose products have been granted fast-track status at the European Medicines Agency

Review Pathway Regulation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • GSK Pfizer HIV
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • GlaxoSmithKline PLC
  • Senior Management
  • Jerome Andries, CFO
    John Pottage, MD, CSO & CMO
    Gregory Reinaud, Head, Global Commercial Strategy
  • Contact Info
  • ViiV Healthcare
    Phone: (44) (0)20 8380 6200
    980 Great West Rd.
    Brentford, TW8 9GS
    UK
UsernamePublicRestriction

Register